Neose Technologies

An Essential Competitor Analysis Report on Human Growth Hormones (hGH): Biosimilar Pricing is Not...

yahoo.com
Oct 8, 2008
        

Wednesday October 8, 10:00 am ET DUBLIN, Ireland--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Competitor Analysis: Human Growth Hormone (hGH)" report to their offering. The Competitive Intelligence...

add comment

Neose Technologies to Appeal NASDAQ Global Market Delisting Notification (Business Wire)

yahoo.com
Aug 21, 2008 3 related
        

HORSHAM, Pa.----Neose Technologies, Inc. today announces that it will request a hearing before a Nasdaq Listing Qualifications Panel to appeal an earlier Staff Determination to delist the Company's common stock from the Nasdaq...

add comment
                   

Neose Technologies Reports Second Quarter Financial Results (Business Wire)

yahoo.com
Aug 7, 2008 1,066 related
        

Thursday August 7, 4:00 pm ET HORSHAM, Pa.--(BUSINESS WIRE)--Neose Technologies, Inc. (NasdaqGM:NTEC - News ) today announced financial results for the second quarter ended June 30, 2008. For the quarter ended June 30, 2008,...

comments (1)
                   
genengnews.com: Genetic Engineering genengnews.com

Neose Technologies Reports Second Quarter Financial Results

genengnews.com
Aug 7, 2008 212 related
        

News source: Business Wire Neose Technologies, Inc. (NasdaqGM:NTEC) today announced financial results for the second quarter ended June 30, 2008. For the quarter ended June 30, 2008, the Company reported a net loss of $4.6...

add comment
genengnews.com: Genetic Engineering genengnews.com

Neose to Host Second Quarter 2008 Conference Call (Business Wire)

yahoo.com
Jul 31, 2008 1 related
        

Thursday July 31, 10:04 am ET HORSHAM, Pa.--(BUSINESS WIRE)--Neose Technologies, Inc. (NasdaqGM:NTEC - News ) today announced that it will release financial results for the second quarter of 2008 on Thursday, August 7, 2008,...

add comment
                   

Neose Technologies Announces GlycoPEG-GCSF Abstract Accepted for Poster Presentation at IXth...

redorbit.com
Jul 28, 2008 3 related
        

Neose Technologies, Inc. (Nasdaq GM:NTEC) today announced that a GlycoPEG-GCSF Phase I clinical abstract submitted by the Company's collaborative partner, BioGeneriX AG, has been accepted for a poster presentation at the IXth...

add comment

BenchmarkJournal.com Sector Analysis for NTEC, TONE, VOCL and TSFG

marketwire.com
Jul 17, 2008 20 related
        

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Benchmark Journal. LONDON--(Marketwire - July 17, 2008) - Benchmark Journal brings independent company and sector research together, utilizing top...

add comment
                   

BioGeneriX And Neose Technologies Initiate Phase 2 Trial For GlycoPEG-GCSF

medicalnewstoday.com
Jun 25, 2008 1 related
        

BioGeneriX AG, a member of the ratiopharm Group of companies, and Neose Technologies, Inc. (NasdaqGM:NTEC) announced the initiation of dosing in a Phase 2 trial to evaluate the safety and efficacy of GlycoPEG-GCSF for the...

add comment

Novo Nordisk completes Phase I trial of hemophilia drug

pharmaceutical-business-review.com
Jun 4, 2008 2 related
        

Novo Nordisk and Neose Technologies have announced that Novo Nordisk has completed the initial Phase I clinical trial with NN7128, a long-acting version of NovoSeven Coagulation Factor FVIIa administered intravenously. The...

add comment

Neose Announces Two Abstracts On GlycoPEGylated Factor VIIa Accepted For Presentation At The...

medicalnewstoday.com
May 29, 2008 4 related
        

Neose Technologies, Inc. ... (Nasdaq GM:NTEC) announced that two abstracts submitted by the Company's collaborative partner, Novo Nordisk A/S, relating to GlycoPEGylated recombinant Factor VIIa have been accepted for presentation at the Hemophilia 2008 World Congress,...

add comment
1 2 3 next